These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25396227)

  • 1. New glioblastoma vaccine: safe and immunogenic in phase 1.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(6):1427. PubMed ID: 25396227
    [No Abstract]   [Full Text] [Related]  

  • 2. The contenders. Vaccines and viruses take aim at cancer cells.
    Clancy F
    Minn Med; 2005 Apr; 88(4):24-8. PubMed ID: 15940888
    [No Abstract]   [Full Text] [Related]  

  • 3. Stemline's synthetic multi-peptide cancer vaccine enters Phase 2.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(6):1430. PubMed ID: 25396232
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian cancer vaccine candidate DPX-Survivac: positive interim results from phase 1.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Dec; 8(12):1743. PubMed ID: 23980265
    [No Abstract]   [Full Text] [Related]  

  • 5. Current strategies for vaccination in glioblastoma.
    Dutoit V; Migliorini D; Dietrich PY
    Curr Opin Oncol; 2019 Nov; 31(6):514-521. PubMed ID: 31403483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agenus’ brain cancer vaccine doubles survival rate in GBM patients.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(8):2139-40. PubMed ID: 25424916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX-1401 combined with TLR agonist: positive phase 1 results.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Dec; 8(12):1742. PubMed ID: 23980263
    [No Abstract]   [Full Text] [Related]  

  • 8. Colorectal cancer vaccines in clinical trials.
    Speetjens FM; Zeestraten EC; Kuppen PJ; Melief CJ; van der Burg SH
    Expert Rev Vaccines; 2011 Jun; 10(6):899-921. PubMed ID: 21692708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agenus cancer vaccine extends survival of GBM patients.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(2):252-3. PubMed ID: 24963517
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain cancer vaccine looks promising in small trial.
    Hum Vaccin; 2010 Jul; 6(7):524-5. PubMed ID: 20622518
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicity profiles of HER2/neu peptide anticancer vaccines: the picture from Phase/I and II clinical trials.
    Baxevanis CN; Papamichail M; Perez SA
    Expert Rev Vaccines; 2012 Jun; 11(6):637-40. PubMed ID: 22873121
    [No Abstract]   [Full Text] [Related]  

  • 12. Dendritic cell vaccines to combat glioblastoma.
    Wheeler CJ
    Expert Rev Neurother; 2010 Apr; 10(4):483-6. PubMed ID: 20367199
    [No Abstract]   [Full Text] [Related]  

  • 13. PR1 peptide vaccine in myeloid malignancies.
    Gilbert JA
    Lancet Oncol; 2016 Dec; 17(12):e520. PubMed ID: 28100433
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccines for glioblastoma and high-grade glioma.
    Wheeler CJ; Black KL
    Expert Rev Vaccines; 2011 Jun; 10(6):875-86. PubMed ID: 21692706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile: ImmunoCellular Therapeutics Ltd.
    Yu JS
    Hum Vaccin Immunother; 2012 Dec; 8(12):1745. PubMed ID: 23817320
    [No Abstract]   [Full Text] [Related]  

  • 16. CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.
    Morse MA; Bradley DA; Keler T; Laliberte RJ; Green JA; Davis TA; Inman BA
    Expert Rev Vaccines; 2011 Jun; 10(6):733-42. PubMed ID: 21692696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive phase 2 results for immatics colorectal cancer vaccine.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Mar; 8(3):282. PubMed ID: 22418877
    [No Abstract]   [Full Text] [Related]  

  • 18. In situ vaccination combined with radiotherapy promising for low-grade lymphoma.
    Hum Vaccin Immunother; 2014; 10(12):3429. PubMed ID: 26052588
    [No Abstract]   [Full Text] [Related]  

  • 19. The current status of vaccine development in colorectal cancer.
    Chang DZ
    Clin Adv Hematol Oncol; 2007 Feb; 5(2):109-11, 136. PubMed ID: 17344798
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-small-cell lung carcinoma vaccines in clinical trials.
    Rossi A; Maione P; Schettino C; Bareschino MA; Sacco PC; Ambrosio R; Barbato V; Zeppa R; Palazzolo G; Gridelli C
    Expert Rev Vaccines; 2011 Jun; 10(6):887-97. PubMed ID: 21692707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.